×
News Home

Should You Buy Predictive Oncology Inc (POAI) in Medical Instruments & Supplies Industry?

Thursday, April 15, 2021 09:55 AM | InvestorsObserver Analysts
Should You Buy Predictive Oncology Inc (POAI) in Medical Instruments & Supplies Industry?

Predictive Oncology Inc (POAI) is around the bottom of the Medical Instruments & Supplies industry according to InvestorsObserver. POAI received an overall rating of 14, which means that it scores higher than 14 percent of all stocks. Predictive Oncology Inc also achieved a score of 9 in the Medical Instruments & Supplies industry, putting it above 9 percent of Medical Instruments & Supplies stocks. Medical Instruments & Supplies is ranked 81 out of the 148 industries.

Overall Score - 14
POAI has an Overall Score of 14. Find out what this means to you and get the rest of the rankings on POAI!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Predictive Oncology Inc Stock Today?

Predictive Oncology Inc (POAI) stock is unchanged 0% while the S&P 500 has risen 0.66% as of 9:53 AM on Thursday, Apr 15. POAI is unchanged $0.00 from the previous closing price of $1.18 on volume of 283,495 shares. Over the past year the S&P 500 has risen 49.17% while POAI has fallen -19.73%. POAI lost -$2.21 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Predictive Oncology Inc (POAI) Stock.

You May Also Like